Skip to content


Aptivus (tipranavir) is a small molecule pharmaceutical. Tipranavir was first approved as Aptivus on 2005-06-22. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
Trade Name Aptivus
Common Name Tipranavir
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals: HIV protease inhibitors (saquinavir type)
Get full access now